CRESTONE: Initial efficacy and safety of seribantumab in solid tumors harboring NRG1 fusions Meeting Abstract


Authors: Carrizosa, D. R.; Burkard, M. E.; Elamin, Y. Y.; Desai, J.; Gadgeel, S. M.; Lin, J. J.; Waqar, S. N.; Spigel, D. R.; Chae, Y. K.; Cheema, P. K.; Haura, E. B.; Liu, S. V.; Nguyen, D.; Reckamp, K. L.; Tsai, F. Y. C.; Jansen, V. M.; Drilon, A. E.; Ou, S. H. I.; Camidge, D. R.; Patil, T.
Abstract Title: CRESTONE: Initial efficacy and safety of seribantumab in solid tumors harboring NRG1 fusions
Meeting Title: 2022 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 40
Issue: 16 Suppl.
Meeting Dates: 2022 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2022-06-01
Language: English
ACCESSION: WOS:000863680300899
PROVIDER: wos
DOI: 10.1200/JCO.2022.40.16_suppl.3006
Notes: Meeting Abstract: 3006 -- This meeting was also held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon